Hydrophilic fat-derived acellular matrix scaffold as well as preparation method and application thereof

By washing with treluton X-100 solution and ultrapure water without enzyme, the preparation of fat-derived decellularized matrix biological scaffolds is simplified, and the problems of cumbersome preparation process, high cost and loss of beneficial ingredients in the prior art are solved, and the problem of cumbersome preparation process is achieved. Efficient and low-cost scaffold preparation, retaining key cytokines and protein components.

CN119075007AActive Publication Date: 2024-12-06PLASTIC SURGERY HOSPITAL CHINESE ACADEMY OF MEDICAL SCIENCES
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411166625.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-12-06
Estimated Expiration
2044-08-23

AI Technical Summary

Technical Problem

The existing preparation methods of adipose-derived decellularized matrix biological scaffolds have problems such as insufficient optimization, high cost, cumbersome process and long-term time, resulting in loss of beneficial components and destruction of physical structure.

Method used

Using enzyme-free method, chemical rinsing and ultrapure water washing was carried out through traluton X-100 solution to retain hydrophilic ingredients, simplify the process and reduce costs, omit the isopropanol degreasing step, and improve the fat-forming effect.

Benefits of technology

It effectively improves the fat-forming effect of the scaffold, reduces the preparation cost and time, simplifies the process, retains more beneficial ingredients such as growth factors, and ensures effective DNA removal.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119075007A_ABST
    Figure CN119075007A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biological materials, and particularly relates to a hydrophilic fat-derived acellular matrix scaffold as well as a preparation method and application thereof. The method comprises the following steps: 1) obtaining a hydrophilic adipose-derived acellular matrix precursor from a physically crushed adipose tissue; 2) carrying out chemical rinsing on the hydrophilic fat-derived acellular matrix precursor by adopting a triton X-100 solution to obtain a supernatant and a precipitate; and 3) separating the precipitate obtained in the step 2), washing with ultrapure water, and collecting the precipitate to obtain the hydrophilic fat-derived acellular matrix scaffold. On the basis that beneficial components, namely hydrophilic components, in DAM are reserved, a novel decellularization technical scheme based on an enzyme-free method is provided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomaterials, and in particular relates to a hydrophilic fat-derived acellular matrix scaffold and a preparation method and application thereof. Background Art

[0002] Decellular adipose-derived matrix (DAM) bioscaffolds can achieve adipose tissue regeneration in vivo and be used for soft tissue reconstruction, and have broad clinical application prospects. Since Flynn proposed the classic DAM preparation method in 2010, more than a dozen improved and optimized methods have been reported, but each method has the following main problems:

[0003] 1. The optimization of preparation lacks specificity. All preparation processes include the steps of breaking cells, removing cell components, and removing lipid components. There is no targeted optimization method designed for the purpose of retaining certain beneficial components.

[0004] 2. High preparation cost. The classic decellularization method requires various biological enzymes (trypsin, ribonuclease, deoxyribonuclease, lipase), etc. Although it greatly shortens the total time of decellularization, the cost of the enzyme is very high, and the enzyme comes from cattle, sheep, etc., which increases the risk of introducing xenoantigens.

[0005] 3. The preparation process is cumbersome and time-consuming. The classic decellularization method takes 109 hours, and multiple washing reagents and enzymes are repeatedly used, and the steps are cumbersome. Long-term rinsing will lead to the loss of beneficial ingredients and destroy the physical structure of the scaffold. Among the various optimization methods, the enzyme-free method omits the use of enzymes and shortens the preparation time to a certain extent, but it also takes more than three days. Summary of the invention

[0006] To address the deficiencies of the prior art, the present invention provides a hydrophilic fat-derived decellularized matrix scaffold and a preparation method and application thereof. The present invention proposes a new technical solution for decellularization based on a non-enzymatic method while retaining the beneficial components, i.e., the hydrophilic components, in DAM.

[0007] The technical solution provided by the present invention is as follows:

[0008] A method for preparing a hydrophilic fat-derived acellular matrix scaffold comprises the following steps:

[0009] 1) Obtaining hydrophilic adipose-derived acellular matrix precursor from physically disrupted adipose tissue;

[0010] 2) chemically rinsing the hydrophilic adipose-derived acellular matrix precursor with a triton X-100 solution to obtain a supernatant and a precipitate;

[0011] 3) Separating the precipitate obtained in step 2), washing it with ultrapure water, and collecting the precipitate to obtain a hydrophilic fat-derived decellularized matrix scaffold.

[0012] In the above technical solution:

[0013] Protein spectrum analysis showed that chemical rinsing with triton could retain more protein components than rinsing with NaCl aqueous solution in the first step of the non-enzymatic method.

[0014] Secondly, long water rinsing is set as the last step. At this time, the hydrophilic protein of DAM has been entangled into flocs and is insoluble in water. Rinsing with water will not lose the hydrophilic beneficial protein.

[0015] Finally, since it is a hydrophilic protein and does not contain lipid components, this technical solution can omit the step of isopropanol defatting.

[0016] This is the fundamental reason why the scaffolds prepared by this process have excellent adipogenic effect.

[0017] Specifically, in step 1), the adipose tissue is discarded liposuction adipose tissue.

[0018] Based on the above technical solution, the discarded liposuctioned fat tissue can be utilized.

[0019] Specifically, in step 1), the hydrophilic fat-derived acellular matrix precursor is: a hydrophilic component obtained by separating oil and lipophilic components from fat slurry formed by physical crushing.

[0020] The hydrophilic component can be separated by existing means based on the separation principle of hydrophilic and lipophilic components, or the following method can be used:

[0021] 1. Preparation of stent donor:

[0022] 200ml of discarded liposuction fat tissue was collected from the clinic as a donor. After the coarse fibrous tissue and fascia were picked out, they were divided into 50ml centrifuge tubes, 25ml of fat tissue in each tube, soaked in 25ml PBS, shaken upside down 5 times, and centrifuged at low speed (500G, 2min) to remove grease, blood, swelling fluid, etc., and retain the middle fat layer. PBS washing was repeated three times.

[0023] 2. Physical crushing:

[0024] The washed adipose tissue was collected and centrifuged again to remove as much water as possible. The homogenizer (FJ200-SH, Huxi Ltd., Shanghai, China) was stirred at high speed (20,000 r / min) for 2 minutes until it was completely liquid with no visible particulate components.

[0025] 3. Separation of hydrophilic and lipophilic components: Centrifuge 50 ml of physically broken fat liquid at high speed (3500G, 3min) and take the precipitate as the hydrophilic DAM precursor component. The volume of the hydrophilic DAM precursor is 3.5 ml.

[0026] Specifically, step 2) includes the following steps:

[0027] 2a) Adding hydrophilic adipose-derived acellular matrix precursor and triton X-100 solution into a centrifuge tube;

[0028] 2b) shaking on a shaker;

[0029] 2c) high-speed centrifugation, removing the supernatant, and adding a new triton X-100 solution to the precipitate; or, filtering the liquid component through a filter and adding a new triton X-100 solution to the collected solid component;

[0030] 2d) Repeat steps 2b) to 2c) at least twice to obtain a supernatant and a precipitate.

[0031] Specifically, in step 2a), the volume concentration of tritonX-100 solution is 0.8-1.2%; the volume ratio of hydrophilic adipose-derived acellular matrix precursor to tritonX-100 solution is 1:(9-11).

[0032] Specifically, in step 2b), the operating temperature is 36-38° C.; and the operating time is 4.5-5.5 hours.

[0033] Specifically, in step 2c), the centrifugal force of the high-speed centrifugation is 3400-3600G, and the time is 2.5-3.5min; the volume concentration of the new tritonX-100 solution is 0.8-1.2%.

[0034] Specifically, in step 2c), steps 2b) to 2c) are repeated twice to obtain a supernatant and a precipitate.

[0035] Specifically, step 3) includes the following steps:

[0036] 3a) removing the supernatant by high-speed centrifugation, adding ultrapure water to the precipitate, and shaking on a shaker; or, filtering the liquid component through a filter, and adding new ultrapure water to the collected solid component;

[0037] 3b) high-speed centrifugation to remove the supernatant, add ultrapure water to the precipitate for the second time, and shake on a shaker;

[0038] 3c) high-speed centrifugation to remove the supernatant, add ultrapure water to the precipitate for the third time, and shake on a shaker;

[0039] 3d) centrifuging and collecting the precipitate to obtain a hydrophilic adipose-derived decellularized matrix scaffold.

[0040] Specifically, in step 3a), the volume ratio of the hydrophilic adipose-derived acellular matrix precursor to ultrapure water is 1:(9-11); the shaking temperature is 36-38° C., and the shaking time is 0.4-0.6 hours.

[0041] Specifically, in step 3b), the volume ratio of the hydrophilic adipose-derived acellular matrix precursor to ultrapure water is 1:(9-11); the shaking temperature is 36-38° C., and the shaking time is 6-9 hours.

[0042] Specifically, in step 3c), the volume ratio of the hydrophilic adipose-derived acellular matrix precursor to ultrapure water is 1:(9-11); the shaking temperature is 36-38° C., and the shaking time is 0.4-0.6 hours.

[0043] The present invention also provides a hydrophilic fat-derived acellular matrix scaffold prepared according to the above scheme.

[0044] Specifically, the total content of four key cytokines, bFGF, VEGF, CXCL12 and CCL21, in the hydrophilic fat-derived acellular matrix scaffold is greater than 1 ng / mL.

[0045] The present invention also provides the application of the hydrophilic fat-derived decellularized matrix scaffold for preparing a fat regeneration biological scaffold.

[0046] The beneficial effects of the present invention are as follows:

[0047] 1. Provides a preparation procedure suitable for hydrophilic DAM, effectively improving the adipogenic effect of the scaffold (reference Figure 3 ).

[0048] 2. The preparation cost is reduced. The entire process only uses a 1% dilution of triton X-100 solution, which greatly reduces the cost compared with the classic method of using enzymes.

[0049] 3. The process is simplified, and the entire preparation and rinsing process only takes 25 hours. The short rinsing time ensures the effective removal of DNA (reference Figure 5 ), while retaining more beneficial ingredients, such as growth factors (reference Figure 6 ). BRIEF DESCRIPTION OF THE DRAWINGS

[0050] Figure 1 This is the effect diagram after adding 1% tritonX-100 solution in Example 1.

[0051] Figure 2 This is a diagram of the hydrophilic DAM scaffold obtained in Example 1.

[0052] Figure 3 It is a comparison chart of the adipogenesis-inducing effects of the hydrophilic scaffold prepared by the prior art and the hydrophilic scaffold provided in Example 1 of the present invention implanted in nude mice for 3 weeks.

[0053] Figure 4 It is a comparison chart of protein abundance eluted by NaCl aqueous solution and 1% tritonX-100 solution.

[0054] Figure 5 It is a comparison chart of the residual DNA in the hydrophilic scaffold prepared by the prior art and the hydrophilic scaffold provided in Example 1 of the present invention.

[0055] Figure 6 It is a comparison chart of cytokine content in a hydrophilic scaffold prepared by prior art and a hydrophilic scaffold provided in Example 1 of the present invention. DETAILED DESCRIPTION

[0056] The principles and features of the present invention are described below. The examples given are only used to explain the present invention and are not used to limit the scope of the present invention.

[0057] Unless otherwise specified, the test methods used in the embodiments of the present invention are conventional methods; the materials and reagents used are reagents and materials that can be obtained from commercial channels unless otherwise specified.

[0058] Example 1

[0059] 1. Separate 7 ml of hydrophilic DAM precursor component from physically broken adipose tissue.

[0060] 2. Divide into two tubes for chemical rinsing:

[0061] 2.1. Add 3.5 ml of hydrophilic DAM and 30 ml of 1% tritonX-100 solution to a 50 ml centrifuge tube (volume ratio is 1:10, do not fill it up to allow sufficient space for shaking) (such as Figure 1 shown).

[0062] 2.2. Shake on a shaker at 37°C for 5 hours.

[0063] 2.3. Centrifuge at high speed (3500G, 3min), remove the supernatant, and add 30ml of new 1% triton X-100 to the precipitate.

[0064] 2.4. Repeat 2.2-2.3 three times, for a total of 15 hours.

[0065] 3. Ultrapure water washing:

[0066] 3.1. After high-speed centrifugation, remove the supernatant (1% triton X-100), add 30 ml of ultrapure water to the precipitate, and shake on a shaker at 37°C for 0.5 hours.

[0067] 3.2. After high-speed centrifugation, remove the supernatant, add 30 ml of ultrapure water to the precipitate, and shake on a shaker at 37°C for 7.5 hours.

[0068] 3.3. After high-speed centrifugation, remove the supernatant, add 30 ml of ultrapure water to the precipitate, and shake on a shaker at 37°C for 0.5 hours.

[0069] 3.4. Centrifuge and collect the precipitate as the hydrophilic DAM scaffold. Two tubes totaling 6.5 mL (such as Figure 2 shown).

[0070] Comparative Example 1

[0071] Refer to the preparation method of Example 1, except that the concentration of triton X-100 solution was adjusted to 0.5%, and the result was 2.2-2.3. It needs to be repeated at least five times before the rinse liquid becomes clear. The operation steps and time are increased.

[0072] Comparative Example 2

[0073] Refer to the preparation method of Example 1, except that the concentration of triton X-100 solution is increased to 2%, and 2.2-2.3 needs to be repeated three times, resulting in a significant increase in the time of the subsequent ultrapure water washing step.

[0074] Effect example

[0075] As a comparison, the following prior art "enzyme-free method" was used to prepare the hydrophilic scaffold:

[0076] 1. Soak the hydrophilic DAM precursor in 0.5M NaCl solution and shake at 37℃ for 4 hours. Centrifuge at 3500G for 3 minutes and discard the supernatant.

[0077] 2. Soak the precipitate in 1M NaCl solution and shake at 37℃ for 4 hours. Centrifuge at 3500G for 3 minutes and discard the supernatant.

[0078] 3. Soak the precipitate in ultrapure water and shake overnight at 37°C. Centrifuge at 3500G for 3 minutes and discard the supernatant.

[0079] 4. Soak the precipitate in 1% tritonX-100 solution and shake at 37℃ for 72 hours. Change the solution every 8 hours. Centrifuge at 3500G for 3 minutes and discard the supernatant.

[0080] 5. Soak the precipitate in ultrapure water, shake it on a shaker at 37°C for half an hour, centrifuge it at 3500G for 3 minutes, and discard the supernatant. Repeat twice.

[0081] 6. Soak the precipitate in 99% isopropanol and shake at 37°C for 8 hours. Centrifuge at 3500G for 3 minutes and discard the supernatant.

[0082] 7. Repeat step 5. The obtained precipitate is a hydrophilic scaffold prepared by the prior art.

[0083] like Figure 3 As shown, it is a comparison of the adipogenic effects of the hydrophilic scaffold prepared by the prior art and the hydrophilic scaffold provided in Example 1 of the present invention implanted in nude mice for 3 weeks. It can be seen that the area of ​​adipocytes induced by the hydrophilic scaffold provided in Example 1 of the present invention is significantly larger than that of the prior art hydrophilic scaffold. The scale bar in the figure is 400um.

[0084] like Figure 4 The figure shows the comparison of protein abundance between NaCl aqueous solution and 1% tritonX-100 solution. It can be seen that when the hydrophilic DAM precursor component is chemically rinsed, NaCl aqueous solution elutes more protein components than tritonX-100 solution.

[0085] like Figure 5 As shown, it is a comparison chart of the residual DNA content in the hydrophilic scaffold prepared by the prior art and the hydrophilic scaffold provided in Example 1 of the present invention. It can be seen that there is no significant difference in the residual DNA content in the hydrophilic scaffold prepared by the prior art without enzyme method and the hydrophilic scaffold prepared by Example 1 of the present invention, and both meet the decellularization standard.

[0086] like Figure 6 The figure shows a comparison of the cytokine content in the hydrophilic scaffold prepared by the prior art and the hydrophilic scaffold provided in Example 1 of the present invention. It can be seen that the content of beneficial cytokines retained by the hydrophilic scaffold provided by the present invention is significantly greater than that of the prior art scaffold.

[0087] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing a hydrophilic fat-derived acellular matrix scaffold, characterized in that: The following steps are involved: 1) Obtaining hydrophilic adipose-derived acellular matrix precursor from physically disrupted adipose tissue; 2) chemically rinsing the hydrophilic adipose-derived acellular matrix precursor with a tritonX-100 solution to obtain a supernatant and a precipitate; 3) Separating the precipitate obtained in step 2), washing it with ultrapure water, and collecting the precipitate to obtain a hydrophilic fat-derived decellularized matrix scaffold.

2. The method for preparing the hydrophilic fat-derived acellular matrix scaffold according to claim 1, characterized in that: In step 1), the adipose tissue is discarded liposuction adipose tissue.

3. The method for preparing the hydrophilic fat-derived acellular matrix scaffold according to claim 1, characterized in that: In step 1), the hydrophilic fat-derived acellular matrix precursor is a hydrophilic component obtained by separating oil and lipophilic components from fat slurry formed by physical crushing.

4. The method for preparing the hydrophilic fat-derived acellular matrix scaffold according to claim 1, characterized in that: Step 2) comprises the following steps: 2a) Adding hydrophilic adipose-derived acellular matrix precursor and triton X-100 solution into a centrifuge tube; 2b) shaking on a shaker; 2c) high-speed centrifugation, removing the supernatant, and adding a new triton X-100 solution to the precipitate; or, filtering the liquid component through a filter and adding a new triton X-100 solution to the collected solid component; 2d) Repeat steps 2b) to 2c) at least twice to obtain a supernatant and a precipitate.

5. The method for preparing the hydrophilic fat-derived acellular matrix scaffold according to claim 4, characterized in that: In step 2a), the volume concentration of tritonX-100 solution is 0.8-1.2%; the volume ratio of hydrophilic adipose-derived acellular matrix precursor to tritonX-100 solution is 1:(9-11); In step 2b), the operating temperature is 36-38° C. and the operating time is 4.5-5.5 hours; In step 2c), the centrifugal force of the high-speed centrifugation is 3400-3600G, and the time is 2.5-3.5min; the volume concentration of the new tritonX-100 solution is 0.8-1.2%; In step 2c), steps 2b) to 2c) are repeated twice to obtain a supernatant and a precipitate.

6. The method for preparing the hydrophilic fat-derived acellular matrix scaffold according to claim 1, characterized in that: Step 3) comprises the following steps: 3a) removing the supernatant by high-speed centrifugation, adding ultrapure water to the precipitate, and shaking on a shaker; or, filtering the liquid component through a filter, and adding new ultrapure water to the collected solid component; 3b) high-speed centrifugation to remove the supernatant, add ultrapure water to the precipitate for the second time, and shake on a shaker; 3c) high-speed centrifugation to remove the supernatant, add ultrapure water to the precipitate for the third time, and shake on a shaker; 3d) centrifuging and collecting the precipitate to obtain a hydrophilic adipose-derived decellularized matrix scaffold.

7. The method for preparing the hydrophilic adipose-derived acellular matrix scaffold according to claim 6, characterized in that: In step 3a), the volume ratio of the hydrophilic adipose-derived acellular matrix precursor to ultrapure water is 1:(9-11); the shaking temperature is 36-38° C., and the shaking time is 0.4-0.6 hours; In step 3b), the volume ratio of the hydrophilic adipose-derived acellular matrix precursor to ultrapure water is 1:(9-11); the shaking temperature is 36-38° C., and the time is 6-9 hours; In step 3c), the volume ratio of the hydrophilic adipose-derived acellular matrix precursor to ultrapure water is 1:(9-11); the shaking temperature is 36-38° C., and the shaking time is 0.4-0.6 hours.

8. A hydrophilic adipose-derived acellular matrix scaffold prepared according to the preparation method according to any one of claims 1 to 7.

9. The hydrophilic adipose-derived acellular matrix scaffold according to claim 8, characterized in that: The total content of four cytokines, bFGF, VEGF, CXCL12 and CCL21, was greater than 1 ng / mL.

10. An application of the hydrophilic fat-derived acellular matrix scaffold according to claim 8 or 9, characterized in that: Used to prepare fat regeneration biological scaffolds.

Citation Information

Patent Citations

  • Preparation method of cell matrix-free material for porcine adipose tissue

    CN104548207A

  • Acellular scaffold solution-GelMA hydrogel composite material and preparation method thereof

    CN110665061A

  • Preparation method of adipose tissue extracellular matrix

    CN111603610A

  • Acellular soft tissue-derived matrices and methods for preparing same

    US20170021058A1